Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 455

    1.

    The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial.

    Chaput Y, Magnan A, Gendron A.

    BMC Psychiatry. 2008 Aug 28;8:73.PMID: 18752690 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.

    Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M.

    J Clin Psychiatry. 2009 Apr;70(4):540-9. Epub 2009 Apr 7.PMID: 19358791 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group.

    J Clin Psychopharmacol. 2006 Dec;26(6):600-9. Erratum in: J Clin Psychopharmacol. 2007 Feb;27(1):51. PMID: 17110817 [PubMed - indexed for MEDLINE]Related articles

    4.

    Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.

    Weisler RH, Calabrese JR, Thase ME, Arvekvist R, Stening G, Paulsson B, Suppes T.

    J Clin Psychiatry. 2008 May;69(5):769-82.PMID: 18452345 [PubMed - indexed for MEDLINE]Related articles

    5.

    Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.

    Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Aström M, Brecher M.

    J Clin Psychiatry. 2009 Apr;70(4):526-39. Epub 2009 Apr 7.PMID: 19358790 [PubMed - indexed for MEDLINE]Related articles

    6.

    Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.

    Vulink NC, Denys D, Fluitman SB, Meinardi JC, Westenberg HG.

    J Clin Psychiatry. 2009 Jul;70(7):1001-8. Epub 2009 Jun 2.PMID: 19497245 [PubMed - indexed for MEDLINE]Related articles

    7.

    A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.

    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.

    Int Clin Psychopharmacol. 2008 Sep;23(5):269-75.PMID: 18703936 [PubMed - indexed for MEDLINE]Related articles

    8.

    Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

    Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group.

    CNS Spectr. 2009 Jun;14(6):299-313.PMID: 19668121 [PubMed - indexed for MEDLINE]Related articles

    9.

    Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

    Amsterdam JD, Wang CH, Shwarz M, Shults J.

    J Affect Disord. 2009 Jan;112(1-3):219-30. Epub 2008 May 16.PMID: 18486235 [PubMed - indexed for MEDLINE]Related articles

    10.

    A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

    Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.PMID: 18462573 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

    March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

    Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101. PMID: 17909125 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Quetiapine augmentation in treatment-resistant depression: a naturalistic study.

    Sagud M, Mihaljević-Peles A, Mück-Seler D, Jakovljević M, Pivac N.

    Psychopharmacology (Berl). 2006 Sep;187(4):511-4. Epub 2006 Jun 27.PMID: 16802162 [PubMed - indexed for MEDLINE]Related articles

    13.

    Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group.

    Bipolar Disord. 2007 Jun;9(4):413-25.PMID: 17547587 [PubMed - indexed for MEDLINE]Related articles

    14.

    Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.

    Claudino AM, de Oliveira IR, Appolinario JC, Cordás TA, Duchesne M, Sichieri R, Bacaltchuk J.

    J Clin Psychiatry. 2007 Sep;68(9):1324-32.PMID: 17915969 [PubMed - indexed for MEDLINE]Related articles

    15.

    A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.

    Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assunção-Talbott S.

    J Clin Psychiatry. 2009 Oct;70(10):1348-57.PMID: 19906340 [PubMed - indexed for MEDLINE]Related articles

    16.

    Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

    Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.

    J Affect Disord. 2008 Aug;109(3):251-63. Epub 2008 Jun 24.PMID: 18579216 [PubMed - indexed for MEDLINE]Related articles

    17.

    A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

    Bipolar Disord. 2009 Aug;11(5):483-93.PMID: 19624387 [PubMed - indexed for MEDLINE]Related articles

    18.

    Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].

    Carey PD, Vythilingum B, Seedat S, Muller JE, van Ameringen M, Stein DJ.

    BMC Psychiatry. 2005 Jan 24;5:5.PMID: 15667657 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

    Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK.

    Arch Pediatr Adolesc Med. 2007 Nov;161(11):1026-34.PMID: 17984403 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.

    Brown ES, Garza M, Carmody TJ.

    J Clin Psychiatry. 2008 May;69(5):701-5.PMID: 18312058 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination